In individuals who tested positive for COVID-19, S100A8 expression was notably elevated relative to healthy individuals, reinforcing previous findings suggesting that S100A8/A9 can serve as a biomarker for assessing COVID-19 severity and predicting clinical outcomes [50]. This evidence concerns the gene S100A8 and COVID-19.